Infinity Pharmaceuticals Stock Price

-0.25 (-6.89%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Infinity Pharmaceuticals Inc INFI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.25 -6.89% 3.38 19:58:10
Open Price Low Price High Price Close Price Prev Close
3.42 3.36 3.52 3.38 3.63
Bid Price Ask Price Spread News
3.35 3.45 0.10 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9,709 1,961,120 $ 3.43 $ 6,725,098 - 1.00 - 5.98
Last Trade Time Type Quantity Stock Price Currency
19:39:57 41 $ 3.35 USD


Draw Mode:

Infinity Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 299.87M 88.72M 86.80M $ 1.72M $ - -0.68 -6.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 466.12k 3.80%

more financials information »

Infinity Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical INFI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.58383.633.203.451,831,742-0.2038-5.69%
1 Month3.053.893.043.532,122,8070.3310.82%
3 Months3.053.891.482.697,794,3630.3310.82%
6 Months3.653.891.482.784,485,968-0.27-7.4%
1 Year1.105.981.003.033,398,7412.28207.27%
3 Years2.335.980.602.781,319,1081.0545.06%
5 Years1.525.980.602.601,169,8411.86122.37%

Infinity Pharmaceuticals Description

Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments. The company operates in only one segment which is drug development.

Your Recent History
Infinity P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.